| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 660 | 2017 |
| Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts S Wakao, M Kitada, Y Kuroda, T Shigemoto, D Matsuse, H Akashi, ... Proceedings of the National Academy of Sciences 108 (24), 9875-9880, 2011 | 356 | 2011 |
| Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis T Matsushita, T Tateishi, N Isobe, T Yonekawa, R Yamasaki, D Matsuse, ... PloS one 8 (4), e61835, 2013 | 245 | 2013 |
| Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy H Ogata, R Yamasaki, A Hiwatashi, N Oka, N Kawamura, D Matsuse, ... Annals of clinical and translational neurology 2 (10), 960-971, 2015 | 212 | 2015 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 211 | 2019 |
| Anti-neurofascin antibody in patients with combined central and peripheral demyelination N Kawamura, R Yamasaki, T Yonekawa, T Matsushita, S Kusunoki, ... Neurology 81 (8), 714-722, 2013 | 187 | 2013 |
| Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration D Matsuse, M Kitada, M Kohama, K Nishikawa, H Makinoshima, S Wakao, ... Journal of Neuropathology & Experimental Neurology 69 (9), 973-985, 2010 | 170 | 2010 |
| Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16 A Iwaki, Y Kawano, S Miura, H Shibata, D Matsuse, W Li, H Furuya, ... Journal of medical genetics 45 (1), 32-35, 2008 | 161 | 2008 |
| A nationwide survey of combined central and peripheral demyelination in Japan H Ogata, D Matsuse, R Yamasaki, N Kawamura, T Matsushita, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (1), 29-36, 2016 | 93 | 2016 |
| Autologous mesenchymal stem cell–derived dopaminergic neurons function in parkinsonian macaques T Hayashi, S Wakao, M Kitada, T Ose, H Watabe, Y Kuroda, K Mitsunaga, ... The Journal of clinical investigation 123 (1), 272-284, 2013 | 90 | 2013 |
| Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod ZY Song, R Yamasaki, Y Kawano, S Sato, K Masaki, S Yoshimura, ... PloS one 10 (4), e0124923, 2015 | 85 | 2015 |
| Mesenchymal stem cells as a source of Schwann cells: their anticipated use in peripheral nerve regeneration S Wakao, D Matsuse, M Dezawa Cells Tissues Organs 200 (1), 31-41, 2015 | 69 | 2015 |
| Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances … D Matsuse, M Kitada, F Ogura, S Wakao, M Kohama, J Kira, Y Tabata, ... Tissue engineering part A 17 (15-16), 1993-2004, 2011 | 60 | 2011 |
| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 47 | 2020 |
| Decreased serum vitamin D levels in Japanese patients with multiple sclerosis M Niino, S Sato, T Fukazawa, K Masaki, Y Miyazaki, D Matsuse, ... Journal of neuroimmunology 279, 40-45, 2015 | 44 | 2015 |
| Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial J Palace, DM Wingerchuk, K Fujihara, A Berthele, C Oreja-Guevara, ... Multiple sclerosis and related disorders 47, 102641, 2021 | 36 | 2021 |
| Consistent improvement with eculizumab across muscle groups in myasthenia gravis R Mantegazza, FL O'Brien, M Yountz, JF Howard Jr, REGAIN Study Group, ... Annals of clinical and translational neurology 7 (8), 1327-1339, 2020 | 25 | 2020 |
| Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonβ-1b therapy in a patient with childhood-onset multiple sclerosis D Matsuse, H Ochi, K Tashiro, T Nomura, H Murai, T Taniwaki, J Kira Internal medicine 44 (1), 68-72, 2005 | 24 | 2005 |
| MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis T Baba, K Shinoda, M Watanabe, S Sadashima, D Matsuse, N Isobe, ... Multiple sclerosis and related disorders 30, 48-50, 2019 | 23 | 2019 |
| Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study H Murai, A Uzawa, Y Suzuki, T Imai, H Shiraishi, H Suzuki, M Okumura, ... Journal of the neurological sciences 407, 116419, 2019 | 20 | 2019 |
